FIANLIMAB
UNII OX5LRQ5H6K

Substance Identification & Data

This profile provides standardized clinical and technical data for Fianlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OX5LRQ5H6K.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2126132-98-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
OX5LRQ5H6K
CAS Registry Number
2126132-98-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FIANLIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11182
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
FG-148
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fianlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FIANLIMAB

Common Names & Synonyms

ANTI-LAG-3 MONOCLONAL ANTIBODY REGN3767
FIANLIMAB [INN]
FIANLIMAB [USAN]
FIANLIMAB [WHO-DD]
RECOMBINANT HUMAN IGG4 KAPPA ANTI LAG-3 MONOCLONAL ANTIBODY REGN3767

Technical Codes

REGN3767
REGN-3767